Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

HTTPS

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Environmental Topics
  • Laws & Regulations
  • Report a Violation
  • About EPA
Risk Assessment
Contact Us

Evaluating impacts of human physiological variability on distributions of internal dose metrics

On this page:

  • Overview
The chemical risk assessment process often involves dosimetric calculations that translate applied doses into internal dose metrics (DMs). Because of physiological variability in humans, it may be useful to treat DMs as distributions rather than scalars. In this work, we sought to understand general features of DM distributions and tested the hypothesis that DMs are lognormally distributed. To accomplish this, we used a physiologically based pharmacokinetic (PBPK) model for chloroform to calculate internal DMs. Applying Monte Carlo (MC) methods to account for variability in PBPK model parameters, we generated samples of DMs to analyze their distributional shapes. Next, we performed a global sensitivity analysis to determine which human parameters have the greatest influence on DMs and generated DM distributions using only the parameters meeting a minimal influence criterion. Using the Shapiro-Wilk normality test we found that some DM distributions are lognormal in shape, but this depended on the distributions chosen to represent parameter variability. Also, the DM distributions tend toward lognormality when more parameters are used. Including only the most influential parameters in the MC analysis yielded comparable DM distributions to those produced using the full MC analysis. Information we generated about DM distributions and techniques demonstrated for identifying influential parameters can be used with other PBPK models to better inform uncertainty in dosimetry.

Impact/Purpose

We estimated dose metric distributions using a physiologically based pharmacokinetic (PBPK) model for chloroform and distributions for human anatomical and physiological parameters. Information we generated about dose metric distributions and techniques demonstrated for identifying influential parameters can be used with other PBPK models to better inform uncertainty in dosimetry.

Citation

Schacht, C., A. Meade, A. Bernstein, B. Prasad, P. Schlosser, H. Tran, AND D. Kapraun. Evaluating impacts of human physiological variability on distributions of internal dose metrics. Joint Mathematics Meetings, Seattle, WA, January 05 - 08, 2022.
  • Risk Assessment Home
  • About Risk Assessment
  • Risk Recent Additions
  • Human Health Risk Assessment
  • Ecological Risk Assessment
  • Risk Advanced Search
    • Risk Publications
  • Risk Assessment Guidance
  • Risk Tools and Databases
  • Superfund Risk Assessment
  • Where you live
Contact Us to ask a question, provide feedback, or report a problem.
Last updated on November 29, 2022
United States Environmental Protection Agency

Discover.

  • Accessibility Statement
  • Budget & Performance
  • Contracting
  • EPA www Web Snapshots
  • Grants
  • No FEAR Act Data
  • Privacy
  • Privacy and Security Notice

Connect.

  • Data
  • Inspector General
  • Jobs
  • Newsroom
  • Open Government
  • Regulations.gov
  • Subscribe
  • USA.gov
  • White House

Ask.

  • Contact EPA
  • EPA Disclaimers
  • Hotlines
  • FOIA Requests
  • Frequent Questions

Follow.